Clinical Approach to Visual Change
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of visual change
Visual changes represent one of the most anxiety-provoking symptoms encountered in primary care, accounting for approximately 4% of all emergency department visits and over 24 million outpatient ophthalmology visits annually in the United States. The lifetime prevalence of significant visual impairment approaches 14% in adults over age 40, with this figure rising dramatically with age. Globally, over 2.2 billion people have some form of vision impairment, making this one of the most common complaints in clinical practice. Early recognition of vision-threatening conditions is critical, as timely intervention can prevent permanent visual loss in many cases.
Definition
Visual change encompasses any alteration in the quality, clarity, or field of vision. This includes decreased visual acuity (blurred vision), visual field defects, metamorphopsia (distortion of images), diplopia (double vision), photopsia (flashing lights), floaters, photophobia, and complete vision loss. Visual changes may be monocular (affecting one eye) or binocular (affecting both eyes), transient or persistent, and may occur suddenly or develop gradually over time.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Seconds to hours | Central retinal artery occlusion, retinal detachment, acute angle-closure glaucoma, vitreous hemorrhage, optic neuritis, stroke | Often indicates vascular or neurological emergency; requires immediate evaluation to prevent permanent vision loss |
| Subacute | Days to weeks | Optic neuritis, giant cell arteritis, compressive lesions, uveitis, corneal ulcer | Suggests inflammatory, infectious, or compressive etiology; urgent but not emergent evaluation |
| Chronic | Months to years | Cataracts, age-related macular degeneration, diabetic retinopathy, open-angle glaucoma, refractive errors | Usually degenerative or progressive conditions; routine evaluation with prevention of further deterioration |
Classification by Character
Monocular Visual Loss
Affects one eye only. When the unaffected eye is covered, the patient notices the visual change. This pattern localizes the problem to the eye itself or the ipsilateral optic nerve (anterior to the optic chiasm). Causes include retinal pathology, optic neuropathy, media opacity, and refractive errors. Central retinal artery occlusion presents as painless monocular vision loss, while acute angle-closure glaucoma presents with pain, halos, and redness.
Binocular Visual Loss
Affects both eyes simultaneously or presents as a visual field defect respecting the vertical midline. This pattern suggests pathology at or posterior to the optic chiasm (chiasm, optic tracts, lateral geniculate nucleus, optic radiations, or visual cortex). Causes include stroke, pituitary tumors, and migraine. Homonymous hemianopia indicates a post-chiasmal lesion, while bitemporal hemianopia suggests chiasmal compression.
Central Vision Loss
Primarily affects the ability to see fine detail, read, and recognize faces. The patient may describe a central scotoma or “blind spot” in their vision. This pattern suggests macular pathology (age-related macular degeneration, macular edema, macular hole) or optic nerve disease affecting the papillomacular bundle. Patients often retain peripheral vision and can navigate but cannot read or drive.
Peripheral Vision Loss
Affects the outer field of vision while sparing central acuity. Patients may bump into objects, have difficulty navigating, or notice a “tunnel vision” effect. This pattern is characteristic of glaucoma, retinitis pigmentosa, and certain retinal detachments. Patients may retain reading ability but have significant functional impairment due to reduced visual field.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Sudden complete loss | Instantaneous loss of vision, often described as “like a curtain falling” or “lights going out” | Central retinal artery occlusion, vitreous hemorrhage, retinal detachment, ischemic optic neuropathy |
| Transient monocular vision loss (amaurosis fugax) | Brief episodes lasting seconds to minutes with complete recovery | Carotid artery disease with retinal emboli, giant cell arteritis, ophthalmic migraine |
| Gradual progressive loss | Slow deterioration over weeks to months, often unnoticed initially | Cataracts, open-angle glaucoma, age-related macular degeneration, diabetic retinopathy |
| Fluctuating vision | Vision varies throughout the day or with certain activities | Diabetic macular edema, dry eye syndrome, early cataracts, poorly controlled diabetes |
| Distortion (metamorphopsia) | Straight lines appear wavy or bent; objects appear wrong size | Macular disease (wet age-related macular degeneration, epiretinal membrane, macular edema) |
| Positive visual phenomena | Flashing lights (photopsia), floaters, or formed visual hallucinations | Posterior vitreous detachment, retinal tear/detachment, migraine aura, Charles Bonnet syndrome |
| Diplopia (double vision) | Seeing two images; may be monocular (persists with one eye covered) or binocular (resolves with one eye covered) | Monocular: corneal irregularity, cataracts, lens dislocation. Binocular: cranial nerve palsy, myasthenia gravis, thyroid eye disease, orbital pathology |
Visual Field Patterns and Anatomical Localization
| Visual Field Defect | Description | Anatomical Location | Common Causes |
|---|---|---|---|
| Monocular scotoma | Blind spot in one eye’s visual field | Retina or optic nerve (pre-chiasmal) | Macular degeneration, optic neuritis, branch retinal artery occlusion |
| Altitudinal defect | Loss of upper or lower half of visual field in one eye | Optic nerve (respects horizontal meridian) | Ischemic optic neuropathy, branch retinal artery occlusion |
| Bitemporal hemianopia | Loss of temporal (outer) visual fields in both eyes | Optic chiasm | Pituitary adenoma, craniopharyngioma, meningioma |
| Homonymous hemianopia | Loss of same side of visual field in both eyes (e.g., right field in both eyes) | Post-chiasmal (optic tract, radiations, or occipital cortex) | Stroke, tumor, trauma, demyelinating disease |
| Quadrantanopia | Loss of one quadrant of visual field | Optic radiations (temporal lobe: superior; parietal lobe: inferior) | Stroke, tumor affecting optic radiations |
Key Concept: The “Big Five” vision-threatening conditions that require urgent recognition are: acute angle-closure glaucoma, central retinal artery occlusion, retinal detachment, giant cell arteritis with ischemic optic neuropathy, and wet age-related macular degeneration. Missing these diagnoses can result in permanent, irreversible vision loss within hours to days.
Impact on Quality of Life
Functional and Psychological Impact
Visual impairment significantly affects quality of life, independence, and mental health. Patients with visual loss have a 2 to 3-fold increased risk of depression, a 2-fold increased risk of falls and hip fractures, and significantly reduced ability to perform activities of daily living. Driving cessation due to visual impairment is associated with increased social isolation and depression. Early detection and treatment of reversible causes, along with low vision rehabilitation services, can substantially improve outcomes.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of visual change
Vision requires the precise coordination of optical structures that focus light, photoreceptors that convert light to electrical signals, and neural pathways that transmit and process visual information. Understanding the anatomy and physiology of the visual system allows clinicians to localize pathology based on the pattern of visual loss and associated symptoms. The visual pathway extends from the cornea through the brain’s occipital cortex, and dysfunction at any point can produce characteristic visual disturbances.
The Visual Pathway: From Light to Perception
| Component | Structure | Function | Pathology Produces |
|---|---|---|---|
| Optical Media | Cornea, aqueous humor, lens, vitreous humor | Transmit and focus light onto the retina; cornea provides 2/3 of refractive power, lens provides 1/3 | Blurred vision, glare, halos; media opacity (cataracts, corneal edema) causes diffuse blur |
| Retina | Photoreceptors (rods and cones), bipolar cells, ganglion cells, retinal pigment epithelium | Phototransduction—converts light energy to electrical signals; processes and transmits to optic nerve | Central or peripheral vision loss, metamorphopsia, photopsia, floaters depending on location |
| Optic Nerve | Approximately 1.2 million axons from retinal ganglion cells; exits globe and travels to chiasm | Transmits visual information from retina to brain; papillomacular bundle carries central vision fibers | Monocular vision loss, central scotoma, altitudinal defects, afferent pupillary defect |
| Optic Chiasm | Junction where nasal retinal fibers cross to contralateral side | Allows integration of visual information; nasal fibers (temporal visual field) cross, temporal fibers do not | Bitemporal hemianopia (compression from above/below); junctional scotoma |
| Optic Tract | Post-chiasmal pathway to lateral geniculate nucleus | Carries ipsilateral temporal and contralateral nasal retinal fibers | Incongruous homonymous hemianopia (visual fields don’t match exactly) |
| Lateral Geniculate Nucleus | Thalamic relay station | Processes and relays visual information to primary visual cortex | Homonymous hemianopia with macular sparing (dual blood supply to macular representation) |
| Optic Radiations | Temporal lobe (Meyer’s loop) and parietal lobe pathways | Transmit visual information to occipital cortex; temporal fibers carry superior visual field, parietal carry inferior | Quadrantanopia: superior (temporal lesion) or inferior (parietal lesion) |
| Primary Visual Cortex | Occipital lobe (calcarine cortex, Brodmann area 17) | Initial cortical processing of visual information; retinotopic organization | Congruous homonymous hemianopia; cortical blindness if bilateral; macular sparing possible |
Mechanisms of Visual Loss by Category
Refractive Mechanisms
Myopia (Nearsightedness)
Mechanism: Eye is too long or cornea too curved; light focuses in front of retina
Clinical relevance: Distant objects appear blurred; increased risk of retinal detachment, glaucoma, and macular degeneration in high myopia
Hyperopia (Farsightedness)
Mechanism: Eye is too short or cornea too flat; light focuses behind retina
Clinical relevance: Near objects require more accommodation; predisposes to acute angle-closure glaucoma due to shallow anterior chamber
Presbyopia
Mechanism: Age-related loss of lens elasticity reduces accommodation
Clinical relevance: Universal after age 40-45; difficulty with near tasks; corrected with reading glasses or bifocals
Media Opacity Mechanisms
| Condition | Mechanism | Visual Effect |
|---|---|---|
| Cataracts | Oxidative damage and protein aggregation in lens fibers cause opacification; nuclear, cortical, or posterior subcapsular types | Gradual painless blur, glare, reduced contrast sensitivity; may cause monocular diplopia |
| Corneal edema | Endothelial dysfunction leads to stromal hydration and loss of transparency | Blurred vision, halos around lights; worse in morning (lid closure traps moisture) |
| Vitreous hemorrhage | Blood in vitreous cavity blocks light transmission; from diabetic retinopathy, retinal tear, trauma | Sudden floaters progressing to vision loss; may clear partially over time |
| Hyphema | Blood in anterior chamber, usually from trauma | Blurred vision; risk of elevated intraocular pressure and corneal blood staining |
Retinal Mechanisms
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Age-related macular degeneration (dry) | Accumulation of drusen (lipid deposits) under retinal pigment epithelium; progressive photoreceptor loss; oxidative stress and inflammation | No proven treatment; antioxidant vitamins (AREDS2 formula) may slow progression in intermediate cases |
| Age-related macular degeneration (wet) | Choroidal neovascularization—abnormal vessels grow under retina, leak fluid and blood; causes rapid central vision loss | Urgent anti-vascular endothelial growth factor (anti-VEGF) injections can stabilize or improve vision if treated early |
| Diabetic retinopathy | Chronic hyperglycemia damages retinal capillaries → microaneurysms, hemorrhages, exudates; ischemia triggers neovascularization | Glycemic control slows progression; laser photocoagulation and anti-VEGF for proliferative disease and macular edema |
| Retinal detachment | Separation of neurosensory retina from retinal pigment epithelium; fluid accumulates in subretinal space; photoreceptors lose blood supply | Surgical emergency—pneumatic retinopexy, scleral buckle, or vitrectomy; delays cause permanent photoreceptor death |
| Central retinal artery occlusion | Embolic or thrombotic occlusion of central retinal artery; retinal ischemia within minutes; inner retina infarcts in 90-100 minutes | Time-critical emergency; treatment window very narrow (less than 4-6 hours); ocular massage, anterior chamber paracentesis, hyperbaric oxygen considered |
| Central retinal vein occlusion | Thrombosis at lamina cribrosa where artery and vein share adventitia; venous congestion causes hemorrhages and macular edema | Anti-VEGF for macular edema; treat underlying risk factors (hypertension, glaucoma); monitor for neovascular complications |
Optic Nerve and Neurological Mechanisms
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Open-angle glaucoma | Progressive retinal ganglion cell death, likely from elevated intraocular pressure and/or vascular insufficiency; characteristic optic disc cupping | Intraocular pressure reduction (drops, laser, surgery) slows progression; irreversible damage requires lifelong monitoring |
| Acute angle-closure glaucoma | Pupillary block causes iris to bow forward, blocking trabecular meshwork; rapid intraocular pressure rise (often greater than 40 mmHg) causes corneal edema and optic nerve ischemia | Emergency—requires immediate pressure reduction with medications; definitive treatment is laser peripheral iridotomy |
| Optic neuritis | Inflammatory demyelination of optic nerve; often associated with multiple sclerosis; immune-mediated axonal damage | High-dose intravenous corticosteroids speed recovery but may not affect final outcome; MRI for MS evaluation |
| Anterior ischemic optic neuropathy (arteritic) | Giant cell arteritis causes vasculitis of posterior ciliary arteries; optic nerve head infarction; can rapidly become bilateral | Emergency—immediate high-dose corticosteroids to prevent fellow eye involvement; temporal artery biopsy for diagnosis |
| Anterior ischemic optic neuropathy (non-arteritic) | Small vessel disease in “disc at risk” (small cup-to-disc ratio); nocturnal hypotension may be contributory | No proven treatment; control vascular risk factors; avoid nocturnal hypotension from aggressive antihypertensive therapy |
| Occipital stroke | Posterior cerebral artery occlusion causes infarction of visual cortex; results in homonymous hemianopia contralateral to lesion | Acute stroke protocols; thrombolysis if within window; rehabilitation for visual field adaptation |
Mechanisms of Diplopia
Monocular Diplopia
Mechanism: Light is split or scattered before reaching the retina due to optical irregularities
Causes: Corneal astigmatism, corneal scars, cataracts (especially posterior subcapsular), lens dislocation, uncorrected refractive error
Key feature: Persists when the unaffected eye is covered
Binocular Diplopia
Mechanism: Misalignment of the visual axes prevents fusion of images from both eyes
Causes: Cranial nerve III, IV, or VI palsy; myasthenia gravis; thyroid eye disease; orbital fracture; decompensated phoria
Key feature: Resolves when either eye is covered
| Cranial Nerve | Muscles Innervated | Deficit Pattern | Common Causes |
|---|---|---|---|
| Cranial nerve III (oculomotor) | Superior, inferior, medial recti; inferior oblique; levator palpebrae; pupil constriction | “Down and out” eye position; ptosis; pupil may be dilated (compressive) or spared (microvascular) | Posterior communicating artery aneurysm (pupil-involving); diabetes, hypertension (pupil-sparing) |
| Cranial nerve IV (trochlear) | Superior oblique | Vertical diplopia worse looking down and toward nose; head tilt away from affected side | Trauma (bilateral), microvascular disease, congenital |
| Cranial nerve VI (abducens) | Lateral rectus | Horizontal diplopia worse at distance; cannot abduct affected eye | Microvascular disease, increased intracranial pressure (false localizing sign), trauma |
Often Overlooked Mechanism: Pupil-Involving Third Nerve Palsy
A third nerve palsy with a dilated, non-reactive pupil is a neurosurgical emergency until proven otherwise. The parasympathetic fibers controlling pupil constriction run on the outside of the nerve and are compressed early by aneurysms (especially posterior communicating artery) but spared in microvascular ischemia (diabetes, hypertension). A patient with a painful third nerve palsy and dilated pupil requires emergent neuroimaging (CT angiography or MR angiography) to evaluate for aneurysm.
Mechanisms of Positive Visual Phenomena
| Phenomenon | Mechanism | Clinical Significance |
|---|---|---|
| Floaters | Vitreous syneresis (liquefaction) with age causes protein aggregates that cast shadows on retina; posterior vitreous detachment releases collagen fibrils | Common and usually benign; new onset with photopsia requires urgent evaluation to rule out retinal tear |
| Photopsia (flashes) | Mechanical traction on retina stimulates photoreceptors; vitreous pulling on peripheral retina during posterior vitreous detachment | Warrants urgent dilated fundus examination; 10-15% of symptomatic posterior vitreous detachment have retinal tear |
| Migraine aura | Cortical spreading depression—wave of neuronal depolarization followed by suppression spreads across visual cortex | Typically builds over 5-20 minutes, lasts less than 60 minutes; scintillating scotoma with fortification spectra is classic |
| Visual hallucinations (Charles Bonnet syndrome) | Visual cortex “releases” spontaneous activity when deprived of normal input; deafferentation phenomenon | Occurs in patients with significant vision loss; patient recognizes hallucinations are not real; no psychiatric pathology |
3. History Taking
A comprehensive approach to eliciting the visual change history
Red Flags — Require Urgent Evaluation
- Sudden painless monocular vision loss — Central retinal artery occlusion, vitreous hemorrhage, retinal detachment
- Painful red eye with halos and nausea — Acute angle-closure glaucoma
- New headache in patient over age 50 with vision loss — Giant cell arteritis
- Jaw claudication or scalp tenderness — Giant cell arteritis
- Flashes and floaters with “curtain” or “veil” — Retinal detachment
- Diplopia with ptosis and dilated pupil — Third nerve palsy from aneurysm
- Visual field defect with neurological symptoms — Stroke or intracranial mass
- Transient monocular vision loss (amaurosis fugax) — Carotid disease, cardiac emboli, giant cell arteritis
Systematic History: The “VISION” Approach
Use the mnemonic “VISION” to ensure comprehensive history taking:
- V — Velocity and nature of onset: Did vision loss occur suddenly (seconds), rapidly (minutes to hours), or gradually (days to weeks)? Was there a precipitating event?
- I — Involvement (one eye or both): Is the problem monocular or binocular? Did you cover each eye to check? Does covering one eye resolve diplopia?
- S — Site of visual loss: Is it central vision (reading, faces), peripheral vision (bumping into things), or the entire field? Upper, lower, or one side?
- I — Intermittent or constant: Is the visual change persistent or does it come and go? How long do episodes last? What brings it on or relieves it?
- O — Other symptoms: Is there pain, redness, headache, photophobia, flashes, floaters, halos, distortion, or neurological symptoms?
- N — Noteworthy history: Past ocular history, systemic diseases (diabetes, hypertension), medications, family history, recent trauma or surgery?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Central retinal artery occlusion | Sudden, painless, profound monocular vision loss; may have preceding amaurosis fugax | “Did your vision go out suddenly like a light switch, or did it fade gradually? Any brief episodes of vision loss before this?” |
| Retinal detachment | Flashes, floaters, then progressive visual field loss like a “curtain” or “shadow” | “Did you notice any new floaters or flashing lights before the vision change? Does it seem like a curtain is covering part of your vision?” |
| Acute angle-closure glaucoma | Severe eye pain, headache, nausea/vomiting, halos around lights, red eye | “Do you have severe eye pain or headache? Are you seeing rainbow-colored halos around lights? Any nausea or vomiting?” |
| Giant cell arteritis | Age over 50, new headache, scalp tenderness, jaw claudication, polymyalgia symptoms | “Do you have a new type of headache? Does your scalp hurt when you brush your hair? Does your jaw get tired when chewing?” |
| Optic neuritis | Subacute monocular vision loss, pain with eye movement, age 20-45, often female | “Does it hurt to move your eye? Did the vision loss develop over hours to days? Have you had any numbness, tingling, or weakness elsewhere?” |
| Wet age-related macular degeneration | Central vision distortion, straight lines appear wavy, rapid progression | “Do straight lines like door frames or telephone poles appear wavy or bent? Has your central vision gotten worse over days to weeks?” |
| Diabetic retinopathy | Known diabetes, fluctuating vision, floaters, gradual or sudden visual changes | “How well controlled is your blood sugar? When was your last eye examination? Have you noticed floaters or spots in your vision?” |
| Migraine with aura | Scintillating scotoma, fortification spectra, builds over minutes, followed by headache | “Do you see shimmering, zigzag lines or a bright spot that grows and moves? Does it build up over 5-20 minutes and then go away?” |
| Stroke (posterior circulation) | Homonymous visual field defect, other neurological symptoms, vascular risk factors | “Is the same side of vision affected in both eyes? Do you have any weakness, numbness, difficulty speaking, or balance problems?” |
| Third nerve palsy | Diplopia, ptosis, eye turned “down and out,” pupil may be dilated | “Is your eyelid drooping? Is the double vision present only when both eyes are open? Do you have a severe headache?” |
| Myasthenia gravis | Fluctuating diplopia and ptosis, worse with fatigue, improves with rest | “Is the double vision or drooping worse at the end of the day or when you’re tired? Does it improve after resting or sleeping?” |
| Cataracts | Gradual painless blur, glare, difficulty driving at night, faded colors | “Has your vision gradually gotten cloudier over months to years? Do you have trouble with glare from oncoming headlights at night?” |
Associated Symptoms and Their Significance
| Associated Symptom | Consider These Conditions | Mechanism |
|---|---|---|
| Eye pain | Acute angle-closure glaucoma, optic neuritis, uveitis, corneal pathology, scleritis | Inflammation, elevated pressure, or corneal/scleral involvement |
| Headache | Giant cell arteritis, acute glaucoma, migraine, pituitary apoplexy, intracranial mass | Vascular inflammation, elevated intraocular or intracranial pressure, mass effect |
| Eye redness | Acute angle-closure glaucoma, uveitis, scleritis, conjunctivitis, corneal ulcer | Ciliary injection indicates intraocular inflammation; conjunctival injection less serious |
| Photophobia | Uveitis, corneal pathology, meningitis, migraine | Inflammation of uveal tract or cornea; ciliary muscle spasm |
| Flashes (photopsia) | Posterior vitreous detachment, retinal tear/detachment, migraine aura | Mechanical retinal stimulation or cortical spreading depression |
| Floaters | Posterior vitreous detachment, vitreous hemorrhage, uveitis, retinal tear | Opacities in vitreous casting shadows on retina |
| Halos around lights | Acute angle-closure glaucoma, cataracts, corneal edema | Light scattering from corneal edema or lens opacity |
| Nausea and vomiting | Acute angle-closure glaucoma, migraine, increased intracranial pressure | Vagal response to pain/pressure; brainstem involvement |
| Neurological symptoms | Stroke, multiple sclerosis, intracranial mass, pituitary apoplexy | Lesion affecting visual pathway and adjacent neural structures |
Medication and Social History
Medications That Cause Visual Changes
- Hydroxychloroquine — Retinal toxicity with chronic use; bull’s eye maculopathy; requires baseline and annual screening
- Ethambutol — Optic neuritis; dose-dependent; central scotoma, color vision loss
- Amiodarone — Corneal deposits (vortex keratopathy), optic neuropathy
- Tamoxifen — Crystalline retinopathy, macular edema, corneal changes
- Topiramate — Acute angle-closure glaucoma from ciliary body edema; myopic shift
- Sildenafil and related drugs — Transient blue-tinted vision, non-arteritic ischemic optic neuropathy (rare)
- Corticosteroids — Cataracts (posterior subcapsular), elevated intraocular pressure
- Digoxin — Yellow-tinted vision (xanthopsia), halos
- Anticholinergics — Blurred near vision, may precipitate angle closure in predisposed eyes
- Vigabatrin — Irreversible peripheral visual field constriction
Relevant Medical and Social History
- Diabetes mellitus: Duration, control (hemoglobin A1c), last retinal examination
- Hypertension: Duration, control, hypertensive retinopathy history
- Cardiovascular disease: Atrial fibrillation, carotid disease, prior stroke
- Autoimmune disease: Multiple sclerosis, lupus, rheumatoid arthritis, sarcoidosis
- Family history: Glaucoma, macular degeneration, retinal detachment
- Smoking: Major risk factor for macular degeneration, cardiovascular disease
- Occupation: Welding (UV keratitis), computer use (dry eye), fine detail work
- Trauma: Recent or remote eye or head injury
- Prior eye surgery: Cataract surgery, refractive surgery, retinal procedures
- Contact lens use: Type, wearing schedule, hygiene (risk for corneal infection)
Timing Patterns and Their Significance
| Timing Pattern | Duration | Suggests |
|---|---|---|
| Seconds to minutes, full recovery | Less than 10 minutes | Amaurosis fugax (retinal transient ischemic attack), papilledema-related obscurations, ocular migraine |
| Minutes, then headache | 5-60 minutes | Migraine with visual aura |
| Hours to days, progressive | Hours to 2 weeks | Optic neuritis, giant cell arteritis, compressive lesion |
| Sudden, persistent | Instantaneous onset, no recovery | Central retinal artery/vein occlusion, vitreous hemorrhage, retinal detachment, ischemic optic neuropathy, stroke |
| Fluctuating throughout day | Variable | Myasthenia gravis (worse with fatigue), dry eye, diabetic macular edema, early cataract |
| Worse in morning | Improves during day | Corneal edema (Fuchs dystrophy), nocturnal lagophthalmos |
| Worse at night | Improves in daylight | Cataracts (glare), retinitis pigmentosa, vitamin A deficiency |
| Months to years, gradual | Chronic progressive | Cataracts, open-angle glaucoma, dry macular degeneration, refractive change |
4. Physical Examination
A systematic approach to examining patients with visual change
Systematic Framework: Use the “External to Internal, Anterior to Posterior” approach for complete examination of patients presenting with visual change. Even in primary care without specialized equipment, a focused examination can identify many vision-threatening conditions.
General Inspection
- Overall appearance: Does the patient appear comfortable or in distress? Holding eye closed (pain)? Head tilted (fourth nerve palsy)?
- Facial symmetry: Ptosis, proptosis, facial weakness, asymmetric pupils visible at distance
- Gait and posture: Difficulty navigating (visual field loss), ataxia (posterior circulation stroke)
- Temporal arteries: Visible swelling, tenderness, reduced pulsation (giant cell arteritis)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood pressure | Hypertension (greater than 180/120), hypotension | Hypertensive emergency can cause retinopathy, papilledema; hypotension may worsen ischemic conditions |
| Heart rate and rhythm | Irregularly irregular rhythm | Atrial fibrillation is source of emboli causing central retinal artery occlusion and stroke |
| Temperature | Fever | Suggests infectious etiology (endophthalmitis, orbital cellulitis, meningitis) |
| Oxygen saturation | Hypoxia | May indicate systemic illness; can worsen ischemic eye conditions |
| Blood glucose | Hyperglycemia, hypoglycemia | Acute hyperglycemia causes lens swelling and refractive changes; hypoglycemia can cause visual symptoms |
Visual Acuity Testing
The “Fifth Vital Sign” of Ophthalmology
Visual acuity must be measured and documented in every patient with visual complaints. Test each eye separately. Use the patient’s corrective lenses or a pinhole occluder to correct refractive error. Record distance acuity (Snellen chart at 20 feet or 6 meters) and near acuity if relevant. If the patient cannot read the largest letter, test ability to count fingers, detect hand motion, or perceive light.
| Visual Acuity Level | Interpretation | Clinical Implications |
|---|---|---|
| 20/20 (6/6) | Normal | Patient sees at 20 feet what a normal eye sees at 20 feet |
| 20/40 (6/12) | Mild reduction | Minimum for unrestricted driving in most jurisdictions |
| 20/200 (6/60) | Legal blindness threshold | Best corrected acuity in better eye; significant functional impairment |
| Count fingers (CF) | Severe reduction | Record distance at which fingers can be counted (e.g., CF at 3 feet) |
| Hand motion (HM) | Profound reduction | Can detect hand movement but not count fingers |
| Light perception (LP) | Near total vision loss | Can detect presence of light; distinguish from no light perception (NLP) |
| No light perception (NLP) | Total blindness | Cannot perceive light even with bright source; worst prognosis |
Pinhole Test: If acuity is reduced, have the patient look through a pinhole occluder. Improvement suggests refractive error as the cause. No improvement suggests pathology beyond refractive error (media opacity, retinal, or neural problem).
Pupil Examination
| Finding | Description | Conditions |
|---|---|---|
| Relative afferent pupillary defect (RAPD) | Swinging flashlight test: affected pupil dilates when light swings to it from normal eye | Optic neuritis, ischemic optic neuropathy, central retinal artery occlusion, advanced glaucoma, large retinal detachment, optic nerve compression |
| Fixed, mid-dilated pupil | Pupil 5-6 mm, non-reactive to light or accommodation | Acute angle-closure glaucoma (ischemic iris sphincter) |
| Dilated pupil with ptosis | Pupil greater than 6 mm, poorly reactive, lid drooping | Third nerve palsy—if pupil involved, suspect compressive lesion (aneurysm); emergency |
| Anisocoria greater in dark | Pupil size difference increases in dim lighting | Horner syndrome (small pupil fails to dilate): ptosis, miosis, anhidrosis |
| Anisocoria greater in light | Pupil size difference increases in bright lighting | Third nerve palsy or pharmacologic mydriasis (large pupil fails to constrict) |
| Irregularly shaped pupil | Non-circular pupil | Posterior synechiae (uveitis), prior surgery, trauma, iris pathology |
External Eye Examination
Orbit and Adnexa
- Proptosis (exophthalmos): Forward displacement of globe; thyroid eye disease, orbital tumor, orbital cellulitis, carotid-cavernous fistula
- Enophthalmos: Posterior displacement; orbital floor fracture, metastatic scirrhous carcinoma, Horner syndrome
- Ptosis: Drooping eyelid; third nerve palsy, Horner syndrome, myasthenia gravis, levator dehiscence
- Lid swelling: Orbital cellulitis (painful, cannot open), preseptal cellulitis, allergic, chalazion
- Lid retraction: Upper lid scleral show; thyroid eye disease (Graves ophthalmopathy)
Conjunctiva and Sclera
| Finding | Pattern | Significance |
|---|---|---|
| Conjunctival injection | Diffuse redness, vessels blanch with phenylephrine | Conjunctivitis, dry eye, subconjunctival hemorrhage—usually not vision-threatening |
| Ciliary flush | Ring of redness around cornea (limbus), does not blanch | Iritis/uveitis, acute glaucoma, keratitis—indicates intraocular inflammation; urgent |
| Subconjunctival hemorrhage | Bright red patch, well-demarcated | Usually benign; check blood pressure; may indicate trauma or bleeding disorder if recurrent |
| Scleral injection (deep) | Violaceous hue, tender to palpation | Scleritis—associated with systemic inflammatory disease; can be vision-threatening |
| Chemosis | Conjunctival edema (boggy swelling) | Allergic reaction, orbital congestion, carotid-cavernous fistula |
Cornea
- Clarity: Hazy cornea suggests edema (acute glaucoma), infiltrate (infection), or scar
- Fluorescein staining: Yellow-green uptake indicates epithelial defect (abrasion, ulcer, herpes dendrite)
- Arcus senilis: White ring at corneal periphery; normal aging finding; if under age 40, check lipids
- Kayser-Fleischer ring: Golden-brown ring at limbus; Wilson disease
- Band keratopathy: Horizontal calcific band; chronic uveitis, hypercalcemia
Anterior Chamber Assessment
Depth Assessment
Penlight test: Shine light from temporal side across anterior chamber. If nasal iris is in shadow, chamber is shallow—increased risk of angle closure. Normal depth shows full illumination of iris.
Cells and Flare
Slit lamp finding: Cells (white blood cells) and flare (protein) in anterior chamber indicate uveitis. Not visible without magnification, but severe inflammation may show hypopyon (layered pus) visible to naked eye.
Visual Field Testing by Confrontation
Technique
Sit facing the patient at arm’s length. Cover your eye opposite the patient’s covered eye. Have patient fixate on your nose. Present fingers in each quadrant and have patient count them. Compare patient’s field to your own. For more sensitivity, present fingers simultaneously in opposite quadrants and ask which side has more—extinction indicates parietal lesion.
| Field Defect Pattern | What You Will Find | Localization |
|---|---|---|
| Central scotoma | Patient cannot see your face while fixating on your nose | Macula or optic nerve (papillomacular bundle) |
| Altitudinal defect | Loss of upper or lower half of vision in one eye | Ischemic optic neuropathy, branch retinal artery occlusion |
| Bitemporal hemianopia | Loss of temporal (outer) fields bilaterally | Chiasmal compression (pituitary tumor) |
| Homonymous hemianopia | Loss of same side of field in both eyes (e.g., right side in both) | Post-chiasmal lesion (stroke, tumor) on opposite side |
| Quadrantanopia | Loss of one quadrant in both eyes | Optic radiation lesion: superior quadrant (temporal lobe), inferior quadrant (parietal lobe) |
| Peripheral constriction | Tunnel vision—only central field preserved | Advanced glaucoma, retinitis pigmentosa |
Extraocular Movement Examination
- Test all six cardinal positions: Right, left, up-right, up-left, down-right, down-left
- Note any limitation: Record which muscle or nerve is affected
- Observe for nystagmus: Note direction, when it occurs (end-gaze versus constant)
- Ask about diplopia: “Do you see double in any direction?” Maximum separation indicates direction of weak muscle
- Cover-uncover test: Deviation with cover indicates tropia (manifest strabismus)
| Cranial Nerve | Movement Deficit | Key Clinical Features |
|---|---|---|
| Third nerve (oculomotor) | Cannot look up, down, or in; ptosis | “Down and out” eye; if pupil dilated → suspect aneurysm (emergency); if pupil spared → likely microvascular |
| Fourth nerve (trochlear) | Cannot look down when eye is adducted | Vertical diplopia worse looking down/in; head tilt away from affected side compensates |
| Sixth nerve (abducens) | Cannot look laterally (abduction) | Horizontal diplopia worse at distance; esotropia (eye turned in); consider raised intracranial pressure |
Fundoscopic Examination
Direct Ophthalmoscopy Tips
Dim room lights. Use right eye to examine patient’s right eye (and vice versa). Start at arm’s length to see red reflex (absence suggests media opacity). Approach along 15-degree temporal angle to find optic disc first. Examine disc, then follow vessels to periphery, then examine macula (ask patient to look at light). Note: dilating drops improve view but should be avoided if angle closure suspected.
| Finding | Description | Conditions |
|---|---|---|
| Absent red reflex | No orange glow from pupil; dark or white reflex | Dense cataract, vitreous hemorrhage, retinal detachment, intraocular tumor |
| Papilledema | Swollen disc with blurred margins, elevated, venous engorgement, absent venous pulsations | Raised intracranial pressure—requires urgent imaging; do not perform lumbar puncture before excluding mass |
| Optic disc pallor | Pale, white disc instead of normal pink-orange color | Optic atrophy from prior ischemia, compression, inflammation, or hereditary optic neuropathy |
| Cupped disc | Enlarged cup-to-disc ratio (greater than 0.5), asymmetry between eyes | Glaucoma—progressive excavation of optic nerve head |
| Cherry red spot | Pale retina with red fovea (fovea lacks inner retinal layers) | Central retinal artery occlusion—emergency; indicates retinal infarction |
| Flame hemorrhages | Superficial hemorrhages following nerve fiber layer | Hypertensive retinopathy, diabetes, central retinal vein occlusion |
| Dot-blot hemorrhages | Deep retinal hemorrhages, round shape | Diabetic retinopathy, retinal vein occlusion |
| Cotton wool spots | White, fluffy patches with feathered edges | Retinal nerve fiber layer infarcts—diabetes, hypertension, HIV, lupus |
| Drusen | Yellow deposits under retinal pigment epithelium in macular area | Age-related macular degeneration—risk of progression to wet form |
| Macular hemorrhage or fluid | Blood or grayish elevation at macula | Wet age-related macular degeneration, diabetic macular edema—may need urgent referral |
| Neovascularization | New abnormal vessels on disc or elsewhere | Proliferative diabetic retinopathy, central retinal vein occlusion—high risk of vitreous hemorrhage |
| Roth spots | Hemorrhages with white centers | Infective endocarditis, leukemia, severe anemia |
Expected Findings by Etiology
| Condition | Visual Acuity | Pupils | External Examination | Fundoscopy |
|---|---|---|---|---|
| Central retinal artery occlusion | Count fingers to light perception | RAPD present | Normal or pale conjunctiva | Cherry red spot, pale retina, box-carring of vessels |
| Acute angle-closure glaucoma | Reduced, variable | Mid-dilated, fixed, oval | Ciliary flush, hazy cornea, shallow chamber | Difficult to visualize due to corneal edema; cupped disc if chronic |
| Retinal detachment | Variable; may be normal initially | RAPD if extensive | Normal | Elevated retina, may see tear; reduced red reflex in area of detachment |
| Optic neuritis | Reduced (variable) | RAPD present | Normal; pain with eye movement | Often normal (retrobulbar); disc swelling in 1/3 |
| Giant cell arteritis | Severely reduced | RAPD present | Tender, non-pulsatile temporal artery | Pale, swollen disc (anterior ischemic optic neuropathy) |
| Third nerve palsy (aneurysm) | Often normal (unless other pathology) | Dilated, non-reactive on affected side | Ptosis, eye “down and out” | Usually normal |
| Wet macular degeneration | Reduced central vision | Normal | Normal | Macular hemorrhage, fluid, drusen |
| Cataracts | Reduced (improves with pinhole) | Normal | Normal; lens opacity may be visible | Reduced red reflex; fundus details obscured |
Important Teaching Point
Normal examination does not exclude serious pathology! Optic neuritis often presents with a normal-appearing fundus (retrobulbar neuritis). Early retinal detachment may not be visible without dilated examination. Posterior circulation stroke may have normal ocular findings except for visual field defect. Amaurosis fugax patients will have normal examination between episodes. Always correlate examination findings with history, and refer urgently if clinical suspicion is high despite normal examination.
5. Differential Diagnosis
Systematic approach organized by probability, duration, and clinical features
Acute Visual Change (Onset: Seconds to Hours)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Posterior vitreous detachment | New floaters and flashes; age over 50; more common in myopes | Shower of floaters, persistent flashes, visual field defect (suggests retinal tear) |
| COMMON | Migraine with visual aura | Scintillating scotoma, fortification spectra; builds over 5-20 minutes; followed by headache | Aura lasting greater than 60 minutes, no headache (first episode), neurological symptoms |
| COMMON | Vitreous hemorrhage | Sudden floaters or vision loss; diabetic retinopathy, posterior vitreous detachment with tear | Dense hemorrhage obscuring view; underlying retinal detachment |
| LESS COMMON | Retinal detachment | Flashes, floaters, then progressive “curtain” over vision; painless | Macula-threatening or macula-off detachment requires urgent surgery |
| LESS COMMON | Central retinal vein occlusion | Sudden painless vision loss; “blood and thunder” fundus; age over 50, hypertension, glaucoma | Severe vision loss (ischemic type); neovascular complications |
| LESS COMMON | Acute angle-closure glaucoma | Severe eye pain, headache, nausea, halos, red eye; Asian ethnicity, hyperopia, age over 50 | Intraocular pressure greater than 40 mmHg; corneal edema; requires emergency treatment |
| UNCOMMON BUT SERIOUS | Central retinal artery occlusion | Sudden, profound, painless monocular vision loss; embolic source (carotid, cardiac) | Treatment window less than 4-6 hours; stroke equivalent—requires urgent workup |
| UNCOMMON BUT SERIOUS | Arteritic anterior ischemic optic neuropathy (giant cell arteritis) | Age over 50, new headache, jaw claudication, scalp tenderness, elevated inflammatory markers | Can become bilateral within days; requires immediate high-dose corticosteroids |
| UNCOMMON BUT SERIOUS | Posterior circulation stroke | Homonymous visual field defect; may have vertigo, ataxia, dysarthria, diplopia | Acute stroke protocols; thrombolysis if within window |
| UNCOMMON BUT SERIOUS | Third nerve palsy (compressive) | Diplopia, ptosis, eye “down and out,” dilated pupil; severe headache | Pupil-involving palsy suggests posterior communicating artery aneurysm—neurosurgical emergency |
Subacute Visual Change (Onset: Days to Weeks)
Step-by-Step Approach to Subacute Vision Loss:
- Step 1: Determine if monocular or binocular — monocular suggests eye or optic nerve; binocular suggests chiasm or posterior pathway
- Step 2: Check for pain — painful suggests inflammation (optic neuritis, uveitis, scleritis)
- Step 3: Look for systemic symptoms — headache, weight loss, fever suggest giant cell arteritis, malignancy, infection
- Step 4: Examine for RAPD — present in optic nerve disease; helps localize pathology
| Probability | Condition | Key Features | Distinguishing Characteristics |
|---|---|---|---|
| COMMON | Optic neuritis | Subacute monocular vision loss over days; pain with eye movement; age 20-45; often female | RAPD present; color vision affected early; may be first presentation of multiple sclerosis |
| COMMON | Anterior uveitis (iritis) | Eye pain, photophobia, redness, blurred vision; may be recurrent | Ciliary flush, miosis, cells and flare in anterior chamber; associated with HLA-B27 conditions |
| LESS COMMON | Non-arteritic anterior ischemic optic neuropathy | Sudden painless vision loss; altitudinal field defect; “disc at risk” (small cup-to-disc ratio) | Age over 50; vascular risk factors; may occur upon waking (nocturnal hypotension) |
| LESS COMMON | Wet age-related macular degeneration | Central vision distortion over days to weeks; straight lines appear wavy | History of dry macular degeneration; macular hemorrhage or fluid on examination |
| LESS COMMON | Corneal ulcer (infectious keratitis) | Pain, redness, photophobia, discharge; contact lens wearer or recent trauma | White infiltrate on cornea; hypopyon may be present; requires cultures and urgent treatment |
| UNCOMMON BUT SERIOUS | Compressive optic neuropathy | Progressive monocular vision loss; may have proptosis or diplopia | Orbital or intracranial mass compressing optic nerve; requires imaging |
| UNCOMMON BUT SERIOUS | Pituitary apoplexy | Sudden severe headache, visual field defects, ophthalmoplegia; known pituitary adenoma | Hemorrhage or infarction of pituitary tumor; may cause bitemporal hemianopia acutely |
| UNCOMMON BUT SERIOUS | Endophthalmitis | Severe pain, redness, vision loss; recent eye surgery or penetrating trauma | Hypopyon, vitritis; requires emergency intravitreal antibiotics |
Chronic Visual Change (Onset: Months to Years)
Step-by-Step Approach to Chronic Vision Loss:
- Step 1: Is it refractive? — Does vision improve with pinhole or current glasses? Refer for refraction
- Step 2: Is it media opacity? — Check red reflex for cataract; examine cornea for opacity
- Step 3: Is it macular disease? — Central vision affected, metamorphopsia, drusen visible
- Step 4: Is it glaucoma? — Check intraocular pressure, cup-to-disc ratio, visual field
- Step 5: Is it diabetic? — Known diabetes, retinal hemorrhages, exudates, neovascularization
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Uncorrected refractive error | 40-50% of visual complaints | Improves with pinhole; myopia, hyperopia, astigmatism, presbyopia |
| COMMON | Cataracts | 25-30% over age 65 | Gradual painless blur, glare, faded colors; reduced red reflex; improves with pinhole initially |
| COMMON | Dry age-related macular degeneration | 15-20% over age 65 | Gradual central vision loss; drusen on examination; metamorphopsia if progressing to wet |
| COMMON | Open-angle glaucoma | 2-3% over age 40 | Asymptomatic until advanced; peripheral field loss; elevated intraocular pressure (not always); cupped disc |
| COMMON | Diabetic retinopathy | 35% of diabetics | Duration and control of diabetes correlate; hemorrhages, exudates, macular edema, neovascularization |
| LESS COMMON | Dry eye syndrome | 5-15% of adults | Fluctuating blur that improves with blinking; foreign body sensation; worse in dry environments |
| LESS COMMON | Epiretinal membrane | 2% over age 50 | Gradual central distortion; macular pucker visible on examination or optical coherence tomography |
| UNCOMMON BUT SERIOUS | Primary open-angle glaucoma (advanced) | Leading cause of irreversible blindness | Tunnel vision; advanced cupping; requires aggressive pressure lowering |
| UNCOMMON BUT SERIOUS | Retinitis pigmentosa | 1 in 4,000 | Night blindness, progressive peripheral field loss; bone spicule pigmentation; family history |
| UNCOMMON BUT SERIOUS | Compressive lesion (pituitary adenoma, meningioma) | Rare | Progressive visual field defect; bitemporal hemianopia; may have endocrine symptoms |
Anatomical Approach to Visual Change
Anterior Segment
Corneal pathology (keratitis, dystrophy, edema)
Cataracts (nuclear, cortical, posterior subcapsular)
Acute angle-closure glaucoma
Anterior uveitis
Hyphema
Lens subluxation
Posterior Segment (Retina/Vitreous)
Age-related macular degeneration
Diabetic retinopathy
Retinal detachment
Retinal vascular occlusion
Vitreous hemorrhage
Posterior vitreous detachment
Optic Nerve
Optic neuritis
Ischemic optic neuropathy (arteritic and non-arteritic)
Open-angle glaucoma
Papilledema
Compressive optic neuropathy
Toxic/nutritional optic neuropathy
Intracranial Visual Pathway
Chiasmal compression (pituitary adenoma)
Optic tract lesions
Occipital stroke
Intracranial mass
Idiopathic intracranial hypertension
Migraine with aura
Drug-Induced Visual Changes
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Hydroxychloroquine | Accumulation in retinal pigment epithelium causing photoreceptor toxicity | Bull’s eye maculopathy; central scotoma; irreversible; risk increases with cumulative dose greater than 1000g | Baseline and annual screening with optical coherence tomography and visual field; stop at first sign of toxicity |
| Ethambutol | Optic neuritis from mitochondrial toxicity; dose-dependent | Central scotoma, decreased color vision (red-green); usually reversible if caught early | Baseline visual acuity and color vision; monthly monitoring; stop if symptoms develop |
| Corticosteroids (systemic and topical) | Posterior subcapsular cataract formation; increased intraocular pressure | Glare, blur from cataracts; asymptomatic pressure rise; risk correlates with dose and duration | Periodic eye examinations for chronic users; pressure checks with topical steroids |
| Topiramate | Ciliary body edema causing anterior rotation of lens-iris diaphragm | Acute angle-closure glaucoma; acute myopic shift; occurs within first month of use | Stop medication immediately; treat acute angle closure; usually resolves with discontinuation |
| Amiodarone | Corneal deposits (vortex keratopathy); optic neuropathy (rare) | Halos and glare from corneal deposits (common, benign); vision loss from optic neuropathy (rare, serious) | Corneal deposits usually do not require stopping; optic neuropathy requires discontinuation |
| Tamoxifen | Crystalline retinopathy, macular edema | Refractile deposits in retina; decreased visual acuity; dose-dependent | Annual eye examinations; consider stopping if significant retinopathy develops |
| Phosphodiesterase-5 inhibitors (sildenafil) | Inhibition of phosphodiesterase-6 in retina; possible ischemic mechanism | Transient blue-tinted vision, increased light sensitivity (common); non-arteritic ischemic optic neuropathy (rare) | Transient symptoms resolve; avoid in patients with prior non-arteritic ischemic optic neuropathy |
| Vigabatrin | Irreversible retinal toxicity affecting peripheral photoreceptors | Bilateral concentric visual field constriction; irreversible; 30-40% of long-term users | Baseline and periodic visual field testing; use only when benefits outweigh risks |
| Digoxin | Photoreceptor dysfunction at toxic levels | Xanthopsia (yellow-tinted vision), halos, blurred vision; indicates toxicity | Check digoxin level; reduce dose or discontinue |
| Anticholinergics | Pupil dilation and ciliary muscle paralysis; may precipitate angle closure in susceptible eyes | Blurred near vision; mydriasis; risk of acute angle-closure in anatomically narrow angles | Use with caution in patients at risk for angle closure; reading glasses for near blur |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Sudden painless monocular vision loss, elderly | Central retinal artery occlusion | Immediate ophthalmology referral; check for embolic source |
| Eye pain, halos, nausea, red eye | Acute angle-closure glaucoma | Check intraocular pressure; emergency ophthalmology referral |
| Flashes and floaters, then “curtain” | Retinal detachment | Same-day dilated fundus examination |
| Age over 50, new headache, jaw claudication | Giant cell arteritis | Immediate ESR, CRP; start corticosteroids before biopsy |
| Pain with eye movement, young woman | Optic neuritis | RAPD check; MRI brain and orbits with contrast |
| Diplopia with ptosis and dilated pupil | Third nerve palsy from aneurysm | Emergent CT angiography or MR angiography |
| Wavy lines, central distortion | Wet age-related macular degeneration | Urgent ophthalmology for possible anti-VEGF injection |
| Gradual blur, glare at night, faded colors | Cataracts | Refraction and cataract evaluation |
| Tunnel vision, cupped disc | Advanced glaucoma | Intraocular pressure check; visual field testing; urgent referral |
| Homonymous visual field defect | Stroke or intracranial mass | Urgent brain imaging (CT or MRI) |
| Bitemporal hemianopia | Pituitary or chiasmal lesion | MRI of brain with pituitary protocol |
| Known diabetic, fluctuating vision | Diabetic macular edema or glucose fluctuation | Dilated fundus examination; optimize glucose control |
| Scintillating scotoma, then headache | Migraine with visual aura | If typical pattern, reassurance; if atypical, consider imaging |
| Transient monocular vision loss (seconds to minutes) | Amaurosis fugax (retinal transient ischemic attack) | Carotid imaging, cardiac workup; treat as stroke equivalent |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Visual Change
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Visual acuity (each eye) | Quantify visual function; document baseline | Reduced acuity; asymmetry between eyes; improvement with pinhole | Use patient’s glasses or pinhole; test at standard distance; document if unable to read chart |
| Pupil examination | Detect afferent pathway dysfunction | Relative afferent pupillary defect indicates optic nerve or extensive retinal disease | Swinging flashlight test in dim room; essential in unilateral vision loss |
| Intraocular pressure | Screen for glaucoma; detect acute angle closure | Normal 10-21 mmHg; greater than 40 mmHg in acute angle closure; can be normal in some glaucoma | Tonometry (Goldmann, Tono-Pen, iCare); essential if eye pain or redness |
| Visual field by confrontation | Detect gross field defects; localize lesion | Homonymous, bitemporal, altitudinal, or central defects | Quick bedside test; formal perimetry needed for subtle defects |
| External eye examination | Identify anterior segment pathology | Redness pattern, corneal clarity, anterior chamber depth, lens opacity | Penlight examination; fluorescein for corneal staining if available |
| Fundoscopy | Examine optic nerve, retina, and vessels | Disc edema, pallor, cupping; retinal hemorrhages, exudates, detachment | Direct ophthalmoscopy; consider dilation if posterior segment pathology suspected |
| Blood pressure | Identify hypertensive emergency; assess vascular risk | Severe hypertension may cause papilledema, retinopathy | Essential in all patients with sudden vision loss |
| Blood glucose | Screen for diabetes; identify acute hyperglycemia | Undiagnosed diabetes causing retinopathy; glucose fluctuations causing refractive changes | Point-of-care or fasting glucose; hemoglobin A1c if diabetes suspected |
Targeted Investigations by Suspected Etiology
If Suspecting Giant Cell Arteritis
Do Not Delay Treatment for Test Results
If clinical suspicion is high, start high-dose corticosteroids immediately. Loss of vision in the second eye can occur within days. Temporal artery biopsy remains positive for up to 2 weeks after starting steroids.
First-Line Tests
- Erythrocyte sedimentation rate (ESR): Usually greater than 50 mm/hr; may be greater than 100 mm/hr. Normal ESR does not exclude diagnosis (up to 20% have normal ESR)
- C-reactive protein (CRP): Usually elevated greater than 25 mg/L; more specific than ESR
- Complete blood count: Normochromic normocytic anemia; thrombocytosis common
- Liver function tests: Elevated alkaline phosphatase in up to 70%
Confirmatory Tests
- Temporal artery biopsy: Gold standard; obtain at least 2 cm sample; skip lesions possible so consider bilateral biopsy. Positive: giant cells, intimal hyperplasia, fragmented internal elastic lamina
- Temporal artery ultrasound: “Halo sign” (hypoechoic ring around vessel lumen); operator-dependent but non-invasive
- MRI or CT angiography: May show vessel wall inflammation; useful when biopsy not feasible
If Suspecting Central Retinal Artery Occlusion
Immediate Assessment
- Dilated fundus examination: Cherry red spot, pale retina, box-carring of vessels
- Intraocular pressure: May attempt to lower to improve perfusion
- ECG: Atrial fibrillation as embolic source
- Blood glucose: Rule out hypoglycemia mimicking visual loss
Embolic Workup (Treat as Stroke Equivalent)
- Carotid imaging: Duplex ultrasound or CT angiography; look for significant stenosis or plaque
- Echocardiography: Transthoracic or transesophageal; evaluate for cardiac source of emboli
- Cardiac monitoring: Holter or telemetry for paroxysmal atrial fibrillation
- Complete blood count, coagulation studies: Hypercoagulable workup if young or recurrent
If Suspecting Optic Neuritis
First-Line Tests
- MRI brain and orbits with gadolinium: Look for optic nerve enhancement; white matter lesions suggest multiple sclerosis. If typical optic neuritis with 1 or more brain lesions, 72% risk of multiple sclerosis at 15 years
- Visual evoked potentials: Prolonged P100 latency indicates demyelination; useful if MRI negative
- Optical coherence tomography: Measures retinal nerve fiber layer; thinning indicates prior optic neuritis
Additional Workup
- Aquaporin-4 antibodies (neuromyelitis optica spectrum disorder): If atypical features, severe vision loss, bilateral, or poor recovery
- Myelin oligodendrocyte glycoprotein (MOG) antibodies: Associated with recurrent optic neuritis with good recovery
- Lumbar puncture: Oligoclonal bands support multiple sclerosis diagnosis; consider if MRI negative but clinical suspicion high
If Suspecting Acute Angle-Closure Glaucoma
Immediate Tests
- Intraocular pressure: Usually greater than 40 mmHg (can be greater than 60 mmHg); diagnostic and determines urgency
- Slit lamp examination: Shallow anterior chamber, corneal edema, mid-dilated fixed pupil, ciliary injection
- Gonioscopy: Closed angle visible (performed by ophthalmologist)
Evaluation of Fellow Eye
- Gonioscopy of fellow eye: Fellow eye at high risk; prophylactic laser iridotomy typically recommended
- Anterior segment optical coherence tomography: Assess anterior chamber depth and angle configuration
- Ultrasound biomicroscopy: Visualize angle anatomy in detail
If Suspecting Retinal Detachment
First-Line Tests
- Dilated fundus examination: Direct visualization of detached retina, retinal breaks; essential for surgical planning
- Indirect ophthalmoscopy: Wider field of view; allows visualization of peripheral retina (performed by ophthalmologist)
If View Obscured (Vitreous Hemorrhage)
- B-scan ultrasonography: Visualize retina through opaque media; can identify detachment, tear, or mass
- Optical coherence tomography: High-resolution macular imaging if media clear enough
If Suspecting Stroke or Intracranial Lesion
Urgent Imaging
- CT head without contrast: Rapid; rules out hemorrhage; may miss early ischemic stroke and posterior fossa lesions
- MRI brain: More sensitive for posterior circulation stroke, demyelination, and small lesions; diffusion-weighted imaging positive within minutes of stroke
- CT angiography or MR angiography: Evaluate for vascular occlusion, aneurysm, or dissection
Additional Workup
- Formal visual field testing: Document and characterize field defect; helps localize lesion
- MRI pituitary protocol: If bitemporal hemianopia or suspected pituitary lesion
- MR venography: If papilledema present; rule out venous sinus thrombosis
If Suspecting Diabetic Retinopathy
Ophthalmic Assessment
- Dilated fundus examination: Grade severity (non-proliferative: mild, moderate, severe; proliferative)
- Optical coherence tomography: Detect and quantify diabetic macular edema; guide treatment
- Fluorescein angiography: Identify neovascularization, macular ischemia, sources of leakage
Systemic Assessment
- Hemoglobin A1c: Assess glycemic control; target generally less than 7%
- Blood pressure: Hypertension accelerates retinopathy progression
- Lipid panel: Dyslipidemia associated with hard exudates
- Renal function: Nephropathy often coexists with severe retinopathy
Advanced Ophthalmic Investigations
| Investigation | What It Shows | When to Order | Key Findings |
|---|---|---|---|
| Optical coherence tomography (OCT) | Cross-sectional imaging of retina and optic nerve at near-histological resolution | Macular disease, glaucoma, optic neuropathy, diabetic macular edema | Retinal thickening (edema), drusen, subretinal fluid, nerve fiber layer thinning |
| Fluorescein angiography | Dynamic imaging of retinal and choroidal vasculature | Diabetic retinopathy, macular degeneration, vascular occlusion, uveitis | Leakage, non-perfusion, neovascularization, staining patterns |
| Automated perimetry (visual field testing) | Quantitative map of visual field sensitivity | Glaucoma, optic neuropathy, neurological visual loss, drug toxicity screening | Arcuate defects (glaucoma), central scotoma, hemianopia, generalized depression |
| Electroretinography (ERG) | Electrical response of retina to light; assesses photoreceptor and bipolar cell function | Retinitis pigmentosa, cone dystrophy, unexplained vision loss with normal fundus | Reduced or absent responses indicate retinal dysfunction |
| Visual evoked potentials (VEP) | Electrical response of visual cortex to patterned stimuli | Optic neuritis, demyelinating disease, unexplained vision loss | Prolonged P100 latency indicates optic nerve conduction delay |
| OCT angiography | Non-invasive imaging of retinal and choroidal vasculature without dye injection | Diabetic retinopathy, macular degeneration, vascular occlusion | Flow voids, neovascularization, macular ischemia |
| B-scan ultrasonography | Imaging of posterior segment when direct visualization not possible | Vitreous hemorrhage, dense cataract, suspected detachment or mass | Retinal detachment appears as membrane; mass versus hemorrhage differentiation |
Empiric Treatment as Diagnostic Tool
When Empiric Treatment Helps Confirm Diagnosis
In some situations, response to treatment supports a diagnosis when testing is inconclusive or unavailable:
- Suspected dry eye syndrome: Trial of artificial tears with improvement in fluctuating blur supports diagnosis
- Suspected refractive error: Trial of refraction with improved acuity confirms diagnosis; eliminates need for extensive workup
- Suspected ocular myasthenia gravis: Ice test (improvement in ptosis after applying ice pack for 2 minutes) or edrophonium test supports diagnosis
- Suspected giant cell arteritis: Rapid improvement of systemic symptoms within 24-48 hours of starting corticosteroids supports diagnosis (vision loss may not improve)
Investigation Algorithm by Presentation
| Presentation | Essential Tests | Consider Adding | Urgency |
|---|---|---|---|
| Sudden painless monocular vision loss | Dilated fundus examination, ESR, CRP, ECG, carotid imaging | Echocardiography, MRI if occipital stroke suspected, hypercoagulable workup if young | EMERGENT |
| Painful vision loss with red eye | Intraocular pressure, slit lamp examination, fluorescein staining | B-scan ultrasound if media opaque, corneal cultures if ulcer | EMERGENT |
| Flashes and floaters | Dilated fundus examination (peripheral retina) | B-scan ultrasound if vitreous hemorrhage obscures view | URGENT (same day) |
| Visual field defect | Formal perimetry, MRI brain | MRI pituitary protocol, CT/MR angiography, lumbar puncture if papilledema | URGENT |
| Diplopia | Cover test, motility examination, pupil examination | MRI/MRA if third nerve with pupil involvement; acetylcholine receptor antibodies if myasthenia suspected | URGENT if pupil-involving third nerve |
| Gradual bilateral vision loss | Refraction, intraocular pressure, dilated fundus examination, OCT | Visual field testing, fluorescein angiography, hemoglobin A1c | ROUTINE |
| Transient vision loss (recovered) | ESR, CRP (if over age 50), carotid imaging, ECG | Echocardiography, Holter monitoring, MRI brain | URGENT (within days) |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for visual change
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Sudden painless monocular vision loss (minutes to hours) | EMERGENT | Immediate ophthalmology referral; consider central retinal artery occlusion (treatment window less than 4-6 hours); check ESR/CRP for giant cell arteritis if age over 50 |
| Severe eye pain with red eye, halos, nausea | EMERGENT | Check intraocular pressure immediately; acute angle-closure glaucoma requires emergency pressure reduction and laser iridotomy |
| Diplopia with ptosis and dilated pupil | EMERGENT | Emergent CT angiography or MR angiography to rule out posterior communicating artery aneurysm; neurosurgical consultation |
| Vision loss with new headache, jaw claudication (age over 50) | EMERGENT | Start high-dose corticosteroids immediately (do not wait for biopsy); ESR, CRP; temporal artery biopsy within 2 weeks |
| Homonymous visual field defect with neurological symptoms | EMERGENT | Activate stroke protocol; emergent brain imaging; consider thrombolysis if within window |
| Flashes and floaters with “curtain” or progressive field loss | URGENT (same day) | Same-day dilated fundus examination; retinal detachment requires surgical repair within 24-48 hours if macula attached |
| New flashes and floaters without field loss | URGENT (within 24-48 hours) | Dilated fundus examination to rule out retinal tear; posterior vitreous detachment with tear requires laser treatment |
| Painful eye with vision loss, recent surgery | URGENT (same day) | Suspect endophthalmitis; immediate ophthalmology referral for vitreous tap and intravitreal antibiotics |
| Transient monocular vision loss (amaurosis fugax) | URGENT (within 24-48 hours) | Treat as retinal transient ischemic attack; carotid imaging, echocardiography, cardiac monitoring; stroke prevention |
| Subacute monocular vision loss with pain on eye movement | URGENT (within days) | Likely optic neuritis; MRI brain and orbits; ophthalmology and neurology referral; consider IV corticosteroids |
| Gradual bilateral vision loss over months | ROUTINE | Comprehensive eye examination; refraction, cataract evaluation, glaucoma screening, retinal examination |
| Difficulty reading, age over 40 | ROUTINE | Likely presbyopia; refraction and reading glasses; rule out macular pathology if not improved with correction |
Step 2: Classify by Key Features
Monocular vs Binocular
Monocular: Pathology anterior to chiasm (eye or optic nerve)
Binocular: Pathology at or posterior to chiasm (neurological)
Key test: Cover each eye separately
Painful vs Painless
Painful: Acute glaucoma, optic neuritis, uveitis, keratitis, scleritis
Painless: Retinal pathology, ischemic optic neuropathy, stroke, cataracts
Exception: Giant cell arteritis causes headache, not eye pain
Acute vs Gradual
Acute (seconds-hours): Vascular, detachment, hemorrhage
Subacute (days-weeks): Inflammatory, compressive
Chronic (months-years): Degenerative, refractive
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Monocular Vision Loss
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Sudden, profound, painless; age over 60; atrial fibrillation or carotid disease | Central retinal artery occlusion | Emergent ophthalmology; ocular massage; lower intraocular pressure; embolic workup |
| Sudden, painless; “blood and thunder” fundus; hypertension | Central retinal vein occlusion | Ophthalmology within 24-48 hours; monitor for neovascular complications; control blood pressure |
| Flashes, floaters, then curtain/shadow; painless | Retinal detachment | Same-day ophthalmology; surgical repair urgency depends on macular status |
| Sudden floaters, decreased red reflex; diabetic | Vitreous hemorrhage | Ophthalmology within 24 hours; B-scan to rule out detachment; may need vitrectomy |
| Severe eye pain, halos, nausea, red eye, hazy cornea | Acute angle-closure glaucoma | Emergency: lower intraocular pressure medically; laser peripheral iridotomy once pressure controlled |
| Age over 50, new headache, jaw claudication, scalp tenderness | Giant cell arteritis | Start prednisone 60-80 mg (or IV methylprednisolone 1g if recent/impending vision loss) immediately; ESR, CRP; biopsy |
| Altitudinal field defect, painless, disc edema; age over 50, vascular risk factors | Non-arteritic anterior ischemic optic neuropathy | Rule out giant cell arteritis; no proven treatment; control vascular risk factors; aspirin |
Algorithm B: Acute Binocular Vision Loss or Visual Field Defect
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Homonymous hemianopia, sudden onset, neurological symptoms | Posterior circulation stroke | Activate stroke protocol; emergent CT/MRI; thrombolysis if within window; neurology consultation |
| Bitemporal hemianopia, headache, may have endocrine symptoms | Pituitary lesion (adenoma or apoplexy) | MRI pituitary protocol; endocrine workup; neurosurgical consultation if apoplexy |
| Bilateral vision loss, papilledema, headache, obese young woman | Idiopathic intracranial hypertension | MRI/MRV to rule out mass and venous sinus thrombosis; lumbar puncture for opening pressure and diagnosis |
| Scintillating scotoma, fortification spectra, builds over minutes, then headache | Migraine with visual aura | If typical: reassurance, migraine management; if atypical or new: brain imaging to rule out structural cause |
| Bilateral sequential vision loss over hours to days, age over 50 | Giant cell arteritis (bilateral) | Emergency: high-dose IV corticosteroids immediately; this is ophthalmologic emergency |
Algorithm C: Diplopia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Diplopia persists with one eye covered | Monocular diplopia: refractive, corneal, lens pathology | Refraction; examine cornea and lens; usually not neurological emergency |
| Diplopia resolves with either eye covered; ptosis, eye “down and out,” pupil dilated | Third nerve palsy—suspect aneurysm | EMERGENT: CT angiography or MR angiography; neurosurgical consultation |
| Third nerve palsy with pupil spared; diabetes or hypertension | Microvascular third nerve palsy | Observation; serial examinations; if no improvement in 3 months or pupil becomes involved, image |
| Vertical diplopia worse looking down; head tilt | Fourth nerve palsy | If isolated and microvascular risk factors, observe; MRI if young, no risk factors, or other neurological signs |
| Horizontal diplopia; cannot abduct eye | Sixth nerve palsy | Consider raised intracranial pressure (false localizing); MRI brain; if isolated with vascular risk factors, may observe |
| Fluctuating diplopia and ptosis; worse with fatigue | Myasthenia gravis | Ice test; acetylcholine receptor antibodies; CT chest for thymoma; neurology referral |
| Proptosis, lid retraction, restricted upgaze, diplopia | Thyroid eye disease | Thyroid function tests; orbital imaging; ophthalmology referral; may need immunosuppression or surgery |
Algorithm D: Chronic Progressive Vision Loss
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Gradual blur, glare, faded colors; reduced red reflex | Cataracts | Refraction; if symptomatic and affecting daily activities, refer for cataract surgery |
| Central distortion, difficulty reading; drusen visible | Age-related macular degeneration | OCT to assess for wet conversion; AREDS2 vitamins for intermediate dry; urgent referral if wet (new distortion) |
| Peripheral field loss, cupped disc; elevated intraocular pressure | Open-angle glaucoma | Formal visual field testing; OCT nerve fiber layer; initiate pressure-lowering therapy |
| Known diabetic; fluctuating vision; hemorrhages on fundoscopy | Diabetic retinopathy | Dilated examination to stage; OCT for macular edema; optimize glycemic control; laser or anti-VEGF as indicated |
| Night blindness, peripheral field constriction; bone spicules on fundoscopy | Retinitis pigmentosa | Electroretinography; genetic testing; low vision services; no proven treatment but research ongoing |
| Progressive bilateral field loss; bitemporal pattern | Compressive chiasmal lesion | MRI brain with pituitary protocol; endocrine evaluation; neurosurgical referral |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient has central retinal artery occlusion but it has been more than 6 hours | Still refer urgently; some benefit may occur; rule out giant cell arteritis | Complete embolic workup (carotid, cardiac); secondary stroke prevention |
| ESR is normal but I still suspect giant cell arteritis | Do not be falsely reassured; up to 20% have normal ESR | Check CRP (more specific); if clinical suspicion high, start steroids and proceed to biopsy |
| Patient has third nerve palsy and I cannot get imaging immediately | If pupil involved: this is an emergency—transfer for emergent imaging | If pupil spared with clear microvascular risk factors: can observe closely with imaging within 24-48 hours |
| Patient has new floaters but no flashes or field defect | Still needs dilated examination within 24-48 hours | If no tear found, reexamine in 4-6 weeks; educate about warning signs |
| Ophthalmology is not immediately available | For emergencies: transfer to facility with ophthalmology; for urgent: telemedicine if available | Start treatment that can be initiated (steroids for giant cell arteritis, pressure-lowering for glaucoma) |
| Patient has gradual vision loss but normal examination | Consider refractive error, dry eye, early cataract, or functional cause | Formal refraction; consider OCT and visual field testing; review medications |
| Patient has vision loss and is on hydroxychloroquine | Stop hydroxychloroquine immediately pending evaluation | Urgent ophthalmology with OCT and visual field; toxicity may not be reversible |
| Patient with diabetes has sudden vision loss | Consider vitreous hemorrhage, retinal detachment, or vascular occlusion | Urgent dilated examination; B-scan if hemorrhage obscures view; check blood glucose |
Troubleshooting Unexplained Vision Loss
Ask These Questions When the Diagnosis Is Unclear
- Did I test visual acuity correctly? Each eye separately, with correction or pinhole?
- Did I check for RAPD? Essential for localizing to optic nerve
- Did I examine with dilation? Many retinal pathologies missed without dilation
- Could this be refractive? Does vision improve with pinhole?
- Could this be functional (non-organic)? Inconsistent findings, normal pupil responses, normal OCT
- Did I get the history right? Monocular versus binocular, acute versus gradual, painful versus painless?
- Did I review all medications? Drug-induced causes are often overlooked
- Should I image the brain? Any homonymous defect, unexplained optic neuropathy, or neurological symptoms warrant MRI
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The “Big Five” emergencies: Central retinal artery occlusion, acute angle-closure glaucoma, retinal detachment, giant cell arteritis, and wet age-related macular degeneration are the vision-threatening conditions you cannot afford to miss. Each has a narrow treatment window.
Always test each eye separately: Patients often do not realize vision loss is monocular until asked to cover each eye. This simple step is the most important localizing information you can obtain.
Pupil-involving third nerve palsy is an aneurysm until proven otherwise: The parasympathetic fibers run on the outside of the nerve and are compressed early by expanding aneurysms. This is a neurosurgical emergency.
Start steroids before biopsy in suspected giant cell arteritis: Do not delay treatment waiting for temporal artery biopsy. Biopsy remains positive for up to 2 weeks after starting corticosteroids. The risk of bilateral blindness far outweighs the inconvenience of a negative biopsy.
Central retinal artery occlusion is a stroke equivalent: These patients need the same embolic workup as a cerebral transient ischemic attack or stroke—carotid imaging, echocardiography, and cardiac monitoring. The 5-year stroke risk is significantly elevated.
A normal ESR does not rule out giant cell arteritis: Up to 20% of biopsy-proven cases have normal ESR. If clinical suspicion is high, check CRP (more specific) and proceed with treatment and biopsy regardless.
New floaters need dilated examination: While most are benign posterior vitreous detachment, 10-15% have a retinal tear. Identifying and treating a tear with laser can prevent retinal detachment.
Amaurosis fugax is a warning—act on it: Transient monocular vision loss lasting seconds to minutes is often a harbinger of central retinal artery occlusion or stroke. Urgent workup and risk factor modification can prevent permanent vision loss or stroke.
Critical Pitfalls to Avoid
Assuming sudden vision loss is “just a migraine”: While migraine aura is common, it builds gradually over 5-20 minutes and resolves within an hour. Sudden, persistent vision loss is never migraine—it requires urgent evaluation for vascular or structural causes.
Missing the dilated pupil in third nerve palsy: A third nerve palsy with a normal pupil is usually microvascular and can be observed. But a dilated, non-reactive pupil indicates compressive pathology—most importantly, posterior communicating artery aneurysm. Always check pupils carefully.
Forgetting to ask about jaw claudication: Jaw claudication (jaw fatigue with chewing) is highly specific for giant cell arteritis but is not volunteered by patients. Ask specifically: “Does your jaw get tired when you chew?” This symptom substantially increases the likelihood of positive biopsy.
Diagnosing “conjunctivitis” in a painful red eye: Not all red eyes are conjunctivitis. Ciliary flush (redness concentrated around the cornea), severe pain, photophobia, or vision loss suggest serious pathology—acute glaucoma, uveitis, or keratitis. Always check visual acuity and intraocular pressure.
Attributing vision changes in diabetics to “just diabetes”: While diabetic retinopathy is common, diabetics can also develop other conditions. Sudden vision loss in a diabetic could be vitreous hemorrhage, retinal detachment, vascular occlusion, or even non-diabetic pathology. Each requires evaluation.
Using dilating drops in suspected acute angle-closure glaucoma: Dilation can precipitate or worsen angle-closure crisis by pushing the iris forward. Check intraocular pressure and anterior chamber depth before dilating any patient with acute eye pain.
Failing to recognize homonymous field defects: Patients may describe vision loss in “one eye” when they actually have a homonymous hemianopia (loss of the same visual field in both eyes). This indicates post-chiasmal pathology—usually stroke. Always test visual fields to both sides.
Overlooking drug-induced causes: Always review the medication list. Hydroxychloroquine, ethambutol, topiramate, and many others cause vision changes. Drug-induced causes are treatable by stopping the offending agent but may be irreversible if not caught early.
Key Takeaways
- Visual acuity is the vital sign of the eye: Always measure and document acuity in each eye separately. This is the single most important piece of objective data.
- Localize before you diagnose: Determine if the problem is monocular or binocular, painful or painless, acute or gradual. This narrows the differential dramatically.
- The RAPD is your friend: A relative afferent pupillary defect indicates optic nerve or severe retinal disease. Its presence or absence helps distinguish between causes.
- Time is vision: Central retinal artery occlusion, acute angle-closure glaucoma, giant cell arteritis, and retinal detachment all have narrow treatment windows. Hours matter.
- Think vascular: Sudden painless monocular vision loss in older adults is vascular (embolic or inflammatory) until proven otherwise. Complete stroke workup is mandatory.
- Think about the other eye: Giant cell arteritis can cause sequential bilateral blindness within days. Acute angle-closure glaucoma puts the fellow eye at risk. Always assess and treat the fellow eye.
- Normal examination does not exclude serious pathology: Optic neuritis may have a normal fundus. Retinal detachment may not be visible without dilation. Amaurosis fugax has a normal examination between episodes. Trust the history.
- When in doubt, dilate: Many posterior segment pathologies are invisible without pupil dilation. If there is no contraindication (suspected angle closure), dilate to see the retina properly.
- Know when to refer urgently: Sudden vision loss, painful red eye with vision loss, new flashes and floaters, diplopia with pupil involvement, and suspected giant cell arteritis all require same-day or emergent ophthalmology evaluation.
- Educate and follow up: Patients with posterior vitreous detachment need to know the warning signs of retinal detachment. Patients with risk factors need regular screening for glaucoma and diabetic retinopathy.
Quick Reference Algorithm
Systematic Approach to Visual Change:
- Assess urgency: Is this emergent, urgent, or routine? Sudden vision loss, painful red eye, and diplopia with pupil changes are emergencies.
- Measure visual acuity: Each eye separately, with correction or pinhole. Document the baseline.
- Determine monocular vs binocular: Have the patient cover each eye. Monocular = eye or optic nerve; binocular = chiasm or brain.
- Check the pupils: Look for RAPD (optic nerve disease) and assess pupil size and reactivity (third nerve, angle closure).
- Examine the eye: External structures, anterior chamber depth, cornea, and fundus. Look for red flags (ciliary flush, hazy cornea, papilledema, cherry red spot).
- Test visual fields: At minimum by confrontation. A homonymous defect requires brain imaging.
- Order targeted tests: Based on clinical suspicion—ESR/CRP for giant cell arteritis, imaging for stroke, dilated examination for retinal pathology.
- Treat time-sensitive conditions immediately: Start steroids for giant cell arteritis, lower pressure in acute glaucoma, refer for retinal detachment repair.
- Refer appropriately: Emergent, urgent, or routine ophthalmology depending on the diagnosis and clinical scenario.
- Address underlying causes: Embolic workup for vascular occlusions, glycemic control for diabetic retinopathy, medication review for drug-induced causes.